HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abdominal Obesity

A condition of having excess fat in the abdomen. Abdominal obesity is typically defined as waist circumferences of 40 inches or more in men and 35 inches or more in women. Abdominal obesity raises the risk of developing disorders, such as DIABETES; HYPERTENSION; and METABOLIC SYNDROME.
Also Known As:
Obesity, Abdominal; Obesity, Visceral; Visceral Obesity; Abdominal Obesities; Central Obesities; Obesities, Abdominal; Obesities, Central; Obesities, Visceral; Obesity, Central; Visceral Obesities; Central Obesity
Networked: 6390 relevant articles (133 outcomes, 691 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Insulin Resistance
2. Obesity
3. Hypertension (High Blood Pressure)
4. Body Weight (Weight, Body)
5. Type 2 Diabetes Mellitus (MODY)

Experts

1. Després, Jean-Pierre: 36 articles (01/2020 - 07/2002)
2. Azizi, Fereidoun: 33 articles (05/2021 - 07/2003)
3. Kelishadi, Roya: 25 articles (01/2022 - 03/2007)
4. Tchernof, André: 21 articles (09/2022 - 12/2003)
5. Qorbani, Mostafa: 21 articles (02/2022 - 09/2013)
6. Lamarche, Benoît: 21 articles (10/2019 - 01/2003)
7. Watts, Gerald F: 20 articles (04/2016 - 02/2002)
8. Onat, Altan: 19 articles (03/2017 - 11/2002)
9. Bergeron, Jean: 17 articles (01/2020 - 02/2002)
10. Chan, Dick C: 17 articles (10/2015 - 02/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Abdominal Obesity:
1. Glucose (Dextrose)FDA LinkGeneric
2. Triglycerides (Triacylglycerol)IBA
3. HDL CholesterolIBA
4. Insulin (Novolin)FDA Link
5. LipidsIBA
6. AdiponectinIBA
7. LeptinIBA
8. C-Reactive ProteinIBA
9. Blood Glucose (Blood Sugar)IBA
10. CholesterolIBA

Therapies and Procedures

1. Therapeutics
2. Glycemic Control
3. Caloric Restriction
4. Gastric Bypass (Roux-en-Y Gastric Bypass)
5. Bariatric Surgery